Molecular assessment of neck dissections supports preserving level IIB lymph nodes in selective neck dissection for laryngeal squamous cell carcinoma with a clinically negative neck

ORL

Volumn 68, Issue 3, 2006, Pages 177-184

  Elsheikh, Mohamed Nasser ^a,c   Mahfouz, Magdy ElSayed ^a   Salim, ElSayed I ^a   Elsheikh, Ehab A ^b  

^a TANTA UNIVERSITY   (Egypt)

^b Tanta Cancer Center   (Egypt)

^c NONE   (Egypt)

Author keywords

Cytokeratin 19; Cytokeratin 20; Laryngeal carcinoma; Molecular detection; Neck metastasis; Selective neck dissection

Indexed keywords

COMPLEMENTARY DNA; CYTOKERATIN 19; CYTOKERATIN 20; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; HEAD AND NECK SURGERY; HUMAN; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; NECK DISSECTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, AGAR GEL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK FACTORS;

EID: 33646095258     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091396     Document Type: Article

References (30)

1. Ferlito A, Silver CE, Rinaldo A, Smith RV: Surgical treatment of the neck in cancer of the larynx. ORL J Otorhinolaryngol Relat Spec 2000;62:217-225.
2. Ferlito A, Gavilàn J, Buckley JG, Shaha AR, Miodoński AJ, Rinaldo A: Functional neck dissection: fact and fiction. Head Neck 2001;23:804-808.
3. Suen JY, Goepfert H: Standardization of neck dissection nomenclature. Head Neck Surg 1987;10:75-77.
4. Calearo CV, Teatini G: Functional neck dissection. Anatomical grounds, surgical technique, clinical observations. Ann Otol Rhinol Laryngol 1983;92:215-222.
5. Köybasioǧlu A, Uslu S, Yilmaz M, Inal E, Ileri F, Asal K: Lymphatic metastasis to the supraretrospinal recess in laryngeal squamous cell carcinoma. Ann Otol Rhinol Laryngol 2002;111:96-99.
6. Kraus DH, Rosenberg DB, Davidson BJ, Shaha AR, Spiro RH, Strong EW, Schantz SP, Shah JP: Supraspinal accessory lymph node metastases in supraomohyoid neck dissection. Am J Surg 1996;172:646-649.
7. Talmi YP, Hoffman HT, Horowitz Z, McCulloch TM, Funk GF, Graham SM, Peleg M, Yahalom R, Teicher S, Kronenberg J: Patterns of metastases to the upper jugular lymph nodes (the 'submuscular recess'). Head Neck 1998;20:682-686.
8. Buckley JG, Feber T: Surgical treatment of cervical node metastases from squamous carcinoma of the upper aerodigestive tract: evaluation of the evidence for modifications of neck dissection. Head Neck 2001;23:907-915.
9. Byers RM, Clayman GL, McGill D, Andrews T, Kare RP, Roberts DB, Goepfert H: Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck 1999;21:499-505.
10. Rinaldo A, Devaney KO, Ferlito A: Immunohistochemical studies in the identification of lymph node micrometastases in patients with squamous cell carcinoma of the head and neck. ORL J Otorhinolaryngol Relat Spec 2004;66:38-41.
11. Hoon DS, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, Kuo C, Foskag LJ, Nizze AJ, Morton DL: Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995;13:2109-2116.
12. Nagler RM: Molecular aspects of oral cancer. Anticancer Res 2002;22:2977-2980.
13. Makino H, Tajiri T, Onda M, Sasajima K, Miyashita M, Nomura T, Maruyama H, Nagasawa S, Tsuchiya Y, Hagiwara N, Yamashita K, Yamaguchi T, Noyama T: Detection of lymph node micrometastasis in esophageal carcinoma. Hepatogastroenterology 2003;50:1407-1410.
14. Moll R, Zimbelmann R, Goldschmidt MD, Keith M, Laufer J, Kasper M, Koch PJ, Franke WW: The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 1993;53:75-93.
15. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD, Coombes RC: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994;54:2986-2990.
16. Silva JM, Dominguez G, Silva J, Garcia JM, Sanchez A, Rodriguez O, Provencio M, Espana P, Bonilla F: Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res 2001;7:2821-2825.
17. Soeth E, Roder C, Juhl H, Kruger U, Kremer B, Kalthoff H: The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase chain reaction is related to the stage of disease. Int J Cancer 1996;69:278-282.
18. Fujii Y, Kageyama Y, Kawakami S, Kihara K, Oshima H: Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res 1999;90:753-757.
19. Nakajima S, Hamada H, Reddy P, Kakunaga T: Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 1985;82:6133-6137.
20. Ayabe T, Tomita M, Matsuzaki Y, Ninomiya H, Hara M, Shimizu T, Edagawa M, Onitsuka T, Hamada M: Micrometastatis and expression of nm23 messenger RNA of lymph nodes from lung cancer and the postoperative clinical outcome. Ann Thorac Cardiovasc Surg 2004;10:152-159.
21. Becker MT, Shores CG, Yu KK, Yarbrough WG: Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:21-27.
22. Lim YC, Song MH, Kim SC, Kim KM, Choi EC: Preserving level IIb lymph nodes in elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:1088-1091.
23. Silverman DA, El-Hajj M, Strome S, Esclamado RM: Prevalence of nodal metastases in the submuscular recess (level IIb) during selective neck dissection. Arch Otolaryngol Head Neck Surg 2003;129:724-728.
24. Redaelli de Zinis LO, Nicolai P, Tomenzoli D, Ghizzardi D, Trimarchi M, Cappiello J, Peretti G, Antonelli AR: The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications. Head Neck 2002;24:913-920.
25. Ferlito A, Shaha A, Rinaldo A: The incidence of lymph node micrometastases in patients pathologically staged NO in cancer of oral cavity and oropharynx. Oral Oncol 2002;38:3-5.
26. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D: Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-435.
27. Hamakawa H, Fukizumi M, Bao Y, Sumida T, Onishi A, Tanioka H, Sato H, Yumoto E: Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer. Clin Exp Metastasis 1999;17:593-599.
28. Cortesina G, Marione T, Galeazzi E, Olivero M, De Stefani A, Bussi M, Valente G, Comoglio PM, Di Renzo MF: Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer 2000;89:286-292.
29. Nieuwenhuis EJ, Leemans CR, Kummer JA, Denkers F, Snow GB, Brakenhoff RH: Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction. Lab Invest 2003;83:1233-1240.
30. Ruud P, Fodstad O, Hovig E: Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 1999;80:119-125.